Afference

Afference is a component technology waiting for a platform that does not yet exist at scale. Its ring only matters if AR/VR/XR devices ship in the hundreds of millions and their makers decide touch feedback is worth adding a second wearable for — two assumptions the last decade of XR has repeatedly deferred. The consumer haptics category has a thin history of independent winners: platform owners internalize the technology once it matters (Meta's Reality Labs has run haptics research programs for years), and until then the market is demos, dev kits, and CES awards rather than revenue. Afference's roughly $18.3M raised is meaningful for a startup but trivial against the R&D budgets of the companies it must either sell to or sell through, and the $15.35M December 2025 round — labeled a Series B — is small for that stage, with no disclosed valuation or named lead, which reads as measured insider conviction rather than competitive escalation. The business model remains unresolved: a "reference design" strategy implies licensing economics that require a patent position strong enough to prevent Samsung, Apple, or Meta from engineering around nerve stimulation — a high bar given decades of prior academic art. Electrical nerve stimulation on skin also carries comfort, calibration, and individual-variability problems that vibration never had; sensations that feel magical in a controlled demo must survive sweaty hands, varied anatomy, and all-day wear. And the nearest adjacent categories — haptic gloves for enterprise, controller rumble for gaming — are already served well enough that the pain point is diffuse. Afference could be years early with an elegant answer to a question the market has not yet asked, and companies in that position usually exit small or run out of road before the platform wave arrives.